Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial | MicrobiomeTrials← Back to trialsNCT06040125
Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2024-01-01Est. Completion: 2027-08-28
Enrollment target: 80 participants Locations- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
- Brigham and Women's Hospital, Boston, Massachusetts, United States
- Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Other microbiome trials you might be interested in
Prostate CancerLeukemiaBreast CancerMelanomaColorectal Cancer
Study Description:
ELEA is an observational cohort study that will collect exposure information and biospecimens from t…
Bethesda, United StatesCompleted Dec 23, 2027
Castrate Resistant Prostate CancerMetastatic Castration-resistant Prostate CancerProstate CancerProstate Carcinoma
This is a single-center, open-label, study of Prostate-Specific Membrane Antigen (PSMA)-targeted radionuclide therapy wi…
San Francisco, United StatesEst. completion May 31, 2027